Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBerkeley Eng Regulatory News (BKY)

Share Price Information for Berkeley Eng (BKY)

Share Price is delayed by 15 minutes
Get Live Data
24.50    -0.80 (-3.16%)
Bid:
24.00
Ask:
25.00
Spread: 1.00 (4.167%)
Market Cap: £109.34m
BKY Live PriceLast checked at - London Stock Exchange

Intraday Berkeley Eng Share Chart

Appendix 3B

9 Nov 2012 07:30

RNS Number : 7405Q
Berkeley Resources Limited
09 November 2012
 



Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12

 

 

Name of entity

 Berkeley Resources Limited

 

ABN

 40 052 468 569

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

$0.475 Employee Incentive Options

 

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

750,000

 

 

3

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

Employee incentive options exercisable at $0.475 each and expiring 22 December 2015. The options vest as follows:

 

- 375,000 on 12 December 2013; and

- 375,000 on 12 December 2014.

 

 

 

 

 

4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Not applicable

 

 

 

5

Issue price or consideration

 

Nil - issued as an incentive to perform.

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

 

 

 

 

Granted to an employee in accordance with the terms of the Berkeley Employee Options Scheme which was approved by Shareholders on 20 September 2011.

 

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

 

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

Not applicable

 

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

Not applicable

 

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

Not applicable

 

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

Not applicable

 

 

 

 

6f

Number of securities issued under an exception in rule 7.2

Not applicable

 

 

 

 

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

Not applicable

 

 

 

 

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

Not applicable

 

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

Not applicable

 

 

 

7

Dates of entering +securities into uncertificated holdings or despatch of certificates

 

 

9 November 2012

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the securities in section 2 if applicable)

 

 

 

179,393,273

11,894,428

 

Ordinary shares

$0.75 Options

 

 

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the securities in section 2 if applicable)

 

 

 

1,000,000

2,241,666

1,000,000

1,750,000

5,500,000

 

$1.25 Incentive Options

$1.35 Incentive Options

$0.41 Incentive Options

$0.475 Incentive Options

$0.45 Unlisted Options

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

Not applicable

 

 

Part 2 ‑ Bonus issue or pro rata issue

 

11

Is security holder approval required?

 

Not applicable

 

12

Is the issue renounceable or non-renounceable?

Not applicable

 

13

Ratio in which the +securities will be offered

Not applicable

 

14

+Class of +securities to which the offer relates

Not applicable

 

15

+Record date to determine entitlements

Not applicable

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

Not applicable

 

17

Policy for deciding entitlements in relation to fractions

 

Not applicable

 

18

Names of countries in which the entity has +security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

Not applicable

 

19

Closing date for receipt of acceptances or renunciations

Not applicable

20

Names of any underwriters

 

 

Not applicable

 

21

Amount of any underwriting fee or commission

Not applicable

 

22

Names of any brokers to the issue

 

 

Not applicable

 

23

Fee or commission payable to the broker to the issue

Not applicable

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of +security holders

Not applicable

 

25

If the issue is contingent on +security holders' approval, the date of the meeting

Not applicable

 

26

Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled

Not applicable

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

Not applicable

 

28

Date rights trading will begin (if applicable)

Not applicable

 

29

Date rights trading will end (if applicable)

 

 

Not applicable

 

30

How do +security holders sell their entitlements in full through a broker?

Not applicable

 

31

How do +security holders sell part of their entitlements through a broker and accept for the balance?

Not applicable

 

 

32

How do +security holders dispose of their entitlements (except by sale through a broker)?

Not applicable

 

33

+Despatch date

 

 

Not applicable

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

 

(a)

Securities described in Part 1

 

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

Entities that have ticked box 34(a)

 Additional securities forming a new class of securities

 

 

Tick to indicate you are providing the information or documents

 

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

37

A copy of any trust deed for the additional +securities

 

 

 

Entities that have ticked box 34(b)

 

38

Number of securities for which +quotation is sought

 

Not applicable

 

 

 

39

Class of +securities for which quotation is sought

 

Not applicable

 

 

 

40

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Not applicable

 

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another security, clearly identify that other security)

 

Not applicable

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the securities in clause 38)

 

 

 

 

 

 

 

 

 

Quotation agreement

 

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

·; The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

·; There is no reason why those +securities should not be granted +quotation.

 

·; An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·; Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

·; If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

Sign here: ............................................................ Date: 9 November 2012

(Director/Company secretary)

 

 

Print name: Clint McGhie

 

== == == == ==

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXFNEAFAFEF
Date   Source Headline
29th Apr 20267:00 amRNSQuarterly Report March 2026
28th Apr 20267:00 amRNSCeasing to be a Substantial Holder
11th Mar 20267:00 amRNSHalf Year Accounts
11th Mar 20267:00 amRNSHalf Year Accounts
6th Feb 20267:00 amRNSFiling of US$1.25 Billion Statement of Claim
29th Jan 20267:00 amRNSQuarterly Report December 2025
21st Jan 20267:00 amRNSChange in Substantial Holder Notice
24th Dec 20257:00 amRNSIssue of Shares on Exercise of Unlisted Options
19th Dec 20257:00 amRNSReport on Payments to Governments
19th Dec 20257:00 amRNSReport on Payments to Governments
28th Nov 20257:00 amRNSResults of Annual General Meeting
31st Oct 20257:00 amRNSQuarterly Report September 2025
28th Oct 20257:00 amRNSPositive Met Test Work Results at Conchas
23rd Oct 20257:00 amRNSNotice of AGM
3rd Oct 20257:00 amRNSDate of Annual General Meeting
29th Aug 20257:00 amRNSChange in Substantial Holder Notice
27th Aug 20257:03 amRNS2025 Annual Report
31st Jul 20257:00 amRNSQuarterly Report June 2025
30th Apr 20257:00 amRNSQuarterly Report March 2025
23rd Apr 20257:00 amRNSChange in Substantial Holder
25th Mar 20257:00 amRNSASX Price Query
13th Mar 20257:00 amRNSHalf-year Report
31st Jan 20257:00 amRNSQuarterly Report December 2024
29th Jan 20257:00 amRNSShallow, thick zones lithium, rubidium intersected
27th Dec 20247:00 amRNSReport on Payments to Govts
19th Nov 20247:00 amRNSResult of AGM
30th Oct 20247:00 amRNSQuarterly Report September 2024
17th Oct 20247:00 amRNSNotice of Substantial Holder
9th Oct 20247:00 amRNSNotice of AGM
24th Sep 20247:00 amRNSDate of Annual General Meeting
27th Aug 20247:00 amRNS2024 Annual Report
31st Jul 20247:00 amRNSQuarterly Report June 2024
28th May 20247:59 amRNSRequest for Arbitration Submitted against Spain
26th Apr 20247:00 amRNSBoard Changes
26th Apr 20247:00 amRNSQuarterly Report March 2024
10th Apr 20247:32 amRNSCommencement of Arbitration against Spain
13th Mar 20247:05 amRNSHalf-Year Accounts
30th Jan 20247:00 amRNSQuarterly Report December 2023
2nd Jan 20247:00 amRNSExpiry of Unlisted Options
27th Dec 20237:00 amRNSPermitting update
21st Dec 20237:00 amRNSReport on Payments to Govts
21st Nov 20237:00 amRNSResult of AGM
30th Oct 20237:00 amRNSSeptember 2023 Quarterly
11th Oct 20237:00 amRNSNotice of AGM
22nd Sep 20237:00 amRNSDate of Annual General Meeting
30th Aug 20237:00 amRNS2023 Annual Report
26th Jul 20237:57 amRNSIssue of Unlisted Options
24th Jul 20237:00 amRNSQuarterly Report June 2023
19th Jul 20237:00 amRNSResults of Meeting
19th Jun 20237:00 amRNSNotice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.